Concept Health Technologies Limited 11784534 false 2023-04-01 2024-03-30 2024-03-30 The principal activity of the company is healthcare Digita Accounts Production Advanced 6.30.9574.0 true 11784534 2023-04-01 2024-03-30 11784534 2024-03-30 11784534 bus:Director1 1 2024-03-30 11784534 core:RetainedEarningsAccumulatedLosses 2024-03-30 11784534 core:ShareCapital 2024-03-30 11784534 core:CurrentFinancialInstruments 2024-03-30 11784534 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-30 11784534 core:Non-currentFinancialInstruments 2024-03-30 11784534 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-30 11784534 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-30 11784534 core:FurnitureFittingsToolsEquipment 2024-03-30 11784534 bus:SmallEntities 2023-04-01 2024-03-30 11784534 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-30 11784534 bus:FilletedAccounts 2023-04-01 2024-03-30 11784534 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-30 11784534 bus:RegisteredOffice 2023-04-01 2024-03-30 11784534 bus:Director1 2023-04-01 2024-03-30 11784534 bus:Director1 1 2023-04-01 2024-03-30 11784534 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-30 11784534 bus:Agent1 2023-04-01 2024-03-30 11784534 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-04-01 2024-03-30 11784534 core:ComputerEquipment 2023-04-01 2024-03-30 11784534 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-30 11784534 countries:EnglandWales 2023-04-01 2024-03-30 11784534 2023-03-31 11784534 bus:Director1 1 2023-03-31 11784534 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-03-31 11784534 core:FurnitureFittingsToolsEquipment 2023-03-31 11784534 2022-04-01 2023-03-31 11784534 2023-03-31 11784534 core:RetainedEarningsAccumulatedLosses 2023-03-31 11784534 core:ShareCapital 2023-03-31 11784534 core:CurrentFinancialInstruments 2023-03-31 11784534 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 11784534 core:Non-currentFinancialInstruments 2023-03-31 11784534 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 11784534 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-03-31 11784534 core:FurnitureFittingsToolsEquipment 2023-03-31 iso4217:GBP xbrli:pure

REGISTRAR OF COMPANIES

Registration number: 11784534

Concept Health Technologies Limited

Unaudited Financial Statements

1 April 2023 to 30 March 2024

image-name

 

Concept Health Technologies Limited

Contents

Accountants' Report

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

4

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Concept Health Technologies Limited
for the Period Ended 30 March 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Concept Health Technologies Limited for the period ended 30 March 2024 as set out on pages 2 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Concept Health Technologies Limited, as a body, in accordance with the terms of our engagement letter dated 21 October 2024. Our work has been undertaken solely to prepare for your approval the accounts of Concept Health Technologies Limited and state those matters that we have agreed to state to the Board of Directors of Concept Health Technologies Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Concept Health Technologies Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Concept Health Technologies Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Concept Health Technologies Limited. You consider that Concept Health Technologies Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Concept Health Technologies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



Dodd & Co Limited
Chartered Accountants
Clint Mill
Cornmarket
PENRITH
CA11 7HW

3 January 2025

 

Concept Health Technologies Limited

(Registration number: 11784534)
Balance Sheet as at 30 March 2024

Note

30 March 2024
£

31 March 2023
£

Fixed assets

 

Intangible assets

4

3,543

6,045

Tangible assets

5

53,183

28,598

 

56,726

34,643

Current assets

 

Debtors

6

200,593

226,873

Cash at bank and in hand

 

204,674

251,057

 

405,267

477,930

Creditors: Amounts falling due within one year

7

(364,370)

(681,446)

Net current assets/(liabilities)

 

40,897

(203,516)

Total assets less current liabilities

 

97,623

(168,873)

Creditors: Amounts falling due after more than one year

7

(26,485)

(31,397)

Provisions for liabilities

(14,279)

-

Net assets/(liabilities)

 

56,859

(200,270)

Capital and reserves

 

Allotted, called up and fully paid share capital

1

1

Profit and loss account

56,858

(200,271)

Total equity

 

56,859

(200,270)

 

Concept Health Technologies Limited

(Registration number: 11784534)
Balance Sheet as at 30 March 2024 (continued)

For the financial period ending 30 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 January 2025
 

.........................................

M F Amin

Director

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
3rd Floor
86-90 Paul Street
LONDON
EC2A 4NE
United Kingdom

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and office equipment

15% reducing balance

Intangible assets

Software development costs and licenses are shown at historical cost. Software development costs and licenses have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Software development costs

5 year straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

Trade debtors

Trade debtors are amounts due from customers for the sale of goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method where due after more than one year.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 3 (2023 - 3).

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

4

Intangible assets

Software development costs
£

Total
£

Cost or valuation

At 1 April 2023

12,508

12,508

At 30 March 2024

12,508

12,508

Amortisation

At 1 April 2023

6,463

6,463

Amortisation charge

2,502

2,502

At 30 March 2024

8,965

8,965

Carrying amount

At 30 March 2024

3,543

3,543

At 31 March 2023

6,045

6,045

5

Tangible assets

Furniture, fittings and office equipment
 £

Total
£

Cost or valuation

At 1 April 2023

32,817

32,817

Additions

30,000

30,000

At 30 March 2024

62,817

62,817

Depreciation

At 1 April 2023

4,219

4,219

Charge for the period

5,415

5,415

At 30 March 2024

9,634

9,634

Carrying amount

At 30 March 2024

53,183

53,183

At 31 March 2023

28,598

28,598

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

6

Debtors

30 March 2024
£

31 March 2023
£

Trade debtors

158,476

164,350

Other debtors

42,117

62,523

200,593

226,873

7

Creditors

Note

30 March 2024
£

31 March 2023
£

Due within one year

 

Loans and borrowings

8

10,640

22,527

Trade creditors

 

1,038

28,327

Taxation and social security

 

3,266

-

Corporation tax liability

 

23,771

-

Other creditors

 

325,655

630,592

 

364,370

681,446

Due after one year

 

Loans and borrowings

8

26,485

31,397

 

Concept Health Technologies Limited

Notes to the Unaudited Financial Statements for the Period from 1 April 2023 to 30 March 2024 (continued)

8

Loans and borrowings

30 March 2024
£

31 March 2023
£

Current loans and borrowings

Bank borrowings

10,640

10,794

Other borrowings

-

11,733

10,640

22,527

30 March 2024
£

31 March 2023
£

Non-current loans and borrowings

Bank borrowings

26,485

31,397

9

Related party transactions

Transactions with the director

2024

At 1 April 2023
£

Advances
£

Repayments
£

Other payments
£

Dividends credited
£

Interest
£

At 30 March 2024
£

M F Amin

F Amin

-

50,275

(35,281)

-

-

74

15,068

               
         

 

Directors' advances are repayable on demand.

Interest has been charged at a rate of 2.25% on advances to directors.